You are looking for

‘Data-driven decision making’ has become a buzzword in policy discussions throughout the past years. On one hand, from a supply point of view, with the digital revolution we generate and have access to an ever-growing pool of data. We continuously collect and analyse information about every aspect of our life, whether personal or professional. On […]

This blog is part of a blog series that showcases the medtech role in the different phases of the COVID-19 pandemic. Read here more COVID-19 related blogs. More info on MedTech Europe’s info hub.  The medical mask was a product once taken for granted, but now is being recognised as a vital tool for public health. […]

Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]

Artificial intelligence (AI) has enormous potential to improve patient outcomes and reduce their variability, making health systems more efficient. But we must take an ethical approach to ensure sustainable implementation and public trust.   As leaders in the medical technology sector, we are playing our part in ensuring that our industry develops advanced data-driven technologies […]

Prevention is better than cure. It’s cheaper too. In fact, preventing future illnesses and preventing complications from existing conditions, are vital to the future sustainability of health systems.  For a vaccine that prevents measles, or a medication that prevents a heart attack, the value is obvious. But what about the value of learning that you […]

The European Patients’ Academy (EUPATI) has trained dozens of patients to engage with companies and decision-makers on medicines development. Now it’s time to think about medtech. I am convinced that the days when experts and clinicians decided what patients want are long gone. Modern healthcare aspires to be patient-centred, while academics, policymakers and industry are […]

Health systems across the European Union are facing numerous challenges – from the ageing of the European population and sustainable financing of health care, to great variations and inequalities in clinical practice within and between countries, a necessary and rising emphasis on patient experience and patient-centredness within health systems, and significant public health threats. The […]

State of play The aim of Europe’s policies and actions in public health is to improve and protect human health, and to support the modernisation of Europe’s health systems – which the EU sees both as improving the quality of its citizens’ lives, and as a contribution to goals involving growth and jobs. While the […]

The new EU regulations on medical devices and in vitro diagnostics (IVDs) share a laudable aim: They seek to modernise the regulatory framework and enhance transparency. The goal, shared by all stakeholders, is to enhance patient safety without harming innovations that improve patient outcomes. However, with these two regulations coming into force by May 2020 […]